{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:18:45Z","timestamp":1792455525360,"version":"4.5.0"},"reference-count":45,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"8","license":[{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2026,7,14]]},"DOI":"10.1167\/iovs.67.8.36","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T14:33:53Z","timestamp":1784039633000},"page":"36","source":"Crossref","is-referenced-by-count":1,"title":["Vitrectomy Status Alters Early Intravitreal Drug Distribution: An Ex Vivo PET-CT Study"],"prefix":"10.1167","volume":"67","author":[{"given":"Sabrina","family":"Wohlfart","sequence":"first","affiliation":[{"name":"The David J Apple Laboratory for Vision Research, University Eye Clinic Heidelberg, Heidelberg Germany"},{"name":"Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hellen Gertrud","family":"Roettgen","sequence":"additional","affiliation":[{"name":"The David J Apple Laboratory for Vision Research, University Eye Clinic Heidelberg, Heidelberg Germany"},{"name":"Institue of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Junker","sequence":"additional","affiliation":[{"name":"The David J Apple Laboratory for Vision Research, University Eye Clinic Heidelberg, Heidelberg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor Aristide","family":"Augustin","sequence":"additional","affiliation":[{"name":"The David J Apple Laboratory for Vision Research, University Eye Clinic Heidelberg, Heidelberg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan Calder","family":"Ackermann","sequence":"additional","affiliation":[{"name":"The David J Apple Laboratory for Vision Research, University Eye Clinic Heidelberg, Heidelberg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludwig","family":"Geisweid","sequence":"additional","affiliation":[{"name":"The David J Apple Laboratory for Vision Research, University Eye Clinic Heidelberg, Heidelberg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd Uwe","family":"Auffarth","sequence":"additional","affiliation":[{"name":"The David J Apple Laboratory for Vision Research, University Eye Clinic Heidelberg, Heidelberg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Mier","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Uhl","sequence":"additional","affiliation":[{"name":"Institue of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Hammer","sequence":"additional","affiliation":[{"name":"The David J Apple Laboratory for Vision Research, University Eye Clinic Heidelberg, Heidelberg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"bib1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000486145","article-title":"Update on intravitreal injections: euretina expert consensus recommendations","volume":"239","author":"Grzybowski","year":"2018","journal-title":"Ophthalmologica"},{"key":"bib2","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.3390\/pharmaceutics14071364","article-title":"Intravitreal application: physicochemical properties of drugs dissolved in silicone oils of different density in comparison to the porcine vitreous body","volume":"14","author":"Hammer","year":"2022","journal-title":"Pharmaceutics"},{"key":"bib3","first-page":"1853","article-title":"In-vitro investigation of the protein binding of different antibiotics in the human vitreous","volume":"43","author":"Schauersberger","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib4","first-page":"4930","article-title":"Fosfomycin in human vitreous: in vitro investigation of the protein binding of fosfomycin in human vitreous \u2013Fosfomycin levels in the vitreous cavity after intravenous administration","volume":"45","author":"Petternel","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib5","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3390\/gels10080501","article-title":"In vitro physicochemical and pharmacokinetic properties of bevacizumab dissolved in silicone oils compared to hydrogel-substitutes and porcine vitreous bodies","volume":"10","author":"Hammer","year":"2024","journal-title":"Gels"},{"key":"bib6","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.preteyeres.2016.12.001","article-title":"Pharmacokinetic aspects of retinal drug delivery","volume":"57","author":"Del Amo","year":"2017","journal-title":"Prog Retin Eye Res"},{"key":"bib7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000499529","article-title":"A prediction model for the intraocular pharmacokinetics of intravitreally injected drugs based on molecular physicochemical properties","volume":"63","author":"Kim","year":"2020","journal-title":"Ophthalmic Res"},{"key":"bib8","first-page":"293","article-title":"Comparison of efficacy of intravitreal ranibizumab between non-vitrectomized and vitrectomized eyes with diabetic macular edema","volume":"38","author":"Chen","year":"2018","journal-title":"Int Ophthalmol"},{"key":"bib9","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ajo.2007.02.048","article-title":"Bevacizumab (Avastin) for diabetic macular edema in previously vitrectomized eyes","volume":"144","author":"Yanyali","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"bib10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/ICB.0b013e318154b734","article-title":"Intravitreal bevacizumab (Avastin) for treatment of persistent macular edema in vitrectomized eyes: limited effect and early recurrence","volume":"1","author":"Kondo","year":"2007","journal-title":"Retin Cases Brief Rep"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s10384-014-0323-7","article-title":"Vision-related quality of life and visual function following intravitreal bevacizumab injection for persistent diabetic macular edema after vitrectomy","volume":"58","author":"Okamoto","year":"2014","journal-title":"Jpn J Ophthalmol"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1097\/IAE.0b013e3182753b12","article-title":"Anatomic and pharmacokinetic properties of intravitreal bevacizumab and ranibizumab after vitrectomy and lensectomy","volume":"33","author":"Christoforidis","year":"2013","journal-title":"Retina"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1097\/00006982-200507000-00002","article-title":"Difference in clearance of intravitreal triamcinolone acetonide between vitrectomized and nonvitrectomized eyes","volume":"25","author":"Chin","year":"2005","journal-title":"Retina"},{"issue":"2","key":"bib14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1167\/tvst.11.2.3","article-title":"Physicochemical properties of explanted silicone oil after use as an intraocular tamponade","volume":"11","author":"Hammer","year":"2022","journal-title":"Transl Vis Sci Technol"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s40942-023-00481-w","article-title":"New approaches to explanting high-viscosity silicone oil in retinal surgery-polyimide cannulas vs extraction sleeves vs a luer-trocar","volume":"9","author":"Hammer","year":"2023","journal-title":"Int J Retina Vitreous"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1097\/IAE.0000000000003432","article-title":"The novel use of high-flow polyimide cannulas to improve silicone oil injectability in vitreoretinal surgery","volume":"42","author":"Hammer","year":"2022","journal-title":"Retina"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/IAE.0b013e3181babe0c","article-title":"Increasing the extensional viscosity of silicone oil reduces the tendency for emulsification","volume":"30","author":"Williams","year":"2010","journal-title":"Retina"},{"issue":"13","key":"bib18","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1167\/iovs.65.13.56","article-title":"Exposure to silicone oil endotamponades induces VEGF antibody aggregation and loss of functionality","volume":"65","author":"Wohlfart","year":"2024","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"bib19","doi-asserted-by":"publisher","first-page":"0044","DOI":"10.1038\/s41551-017-0044","article-title":"Fast-forming hydrogel with ultralow polymeric content as an artificial vitreous body","volume":"1","author":"Hayashi","year":"2017","journal-title":"Nat Biomed Eng"},{"issue":"13","key":"bib20","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1167\/tvst.9.13.34","article-title":"Alginate- and hyaluronic acid-based hydrogels as vitreous substitutes: an in vitro evaluation","volume":"9","author":"Schulz","year":"2020","journal-title":"Transl Vis Sci Technol"},{"issue":"3","key":"bib21","doi-asserted-by":"publisher","first-page":"e0172895","DOI":"10.1371\/journal.pone.0172895","article-title":"Efficacy of two different thiol-modified crosslinked hyaluronate formulations as vitreous replacement compared to silicone oil in a model of retinal detachment","volume":"12","author":"Schnichels","year":"2017","journal-title":"PLoS One"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1097\/ICU.0000000000000745","article-title":"Novel vitreous substitutes: the next frontier in vitreoretinal surgery","volume":"32","author":"Schulz","year":"2021","journal-title":"Curr Opin Ophthalmol"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"837","DOI":"10.3390\/gels9100837","article-title":"Forward light scattering of first to third generation vitreous body replacement hydrogels after surgical application compared to conventional silicone oils and vitreous body","volume":"9","author":"Hammer","year":"2023","journal-title":"Gels"},{"issue":"9","key":"bib24","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1167\/tvst.11.9.14","article-title":"Vitreous substitutes as drug release systems","volume":"11","author":"Schulz","year":"2022","journal-title":"Trans Vis Sci Tech"},{"issue":"1","key":"bib25","first-page":"5485467","article-title":"Distribution of triamcinolone acetonide after intravitreal injection into silicone oil-filled eye","volume":"2016","author":"Da","year":"2016","journal-title":"BioMed Res Int"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"107473","DOI":"10.1016\/j.ejps.2026.107473","article-title":"In vitro analysis of triamcinolone acetonide dissolution and diffusion in vitreous substitutes","volume":"219","author":"Reichel","year":"2026","journal-title":"Eur J Pharm Sci"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"786","DOI":"10.3390\/pharmaceutics15030786","article-title":"Ex vivo visualization of distribution of intravitreal injections in the porcine vitreous and hydrogels simulating the vitreous","volume":"15","author":"Auel","year":"2023","journal-title":"Pharmaceutics"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"4370","DOI":"10.1021\/acs.analchem.5b00140","article-title":"Bayesian deconvolution of mass and ion mobility spectra: from binary interactions to polydisperse ensembles","volume":"87","author":"Marty","year":"2015","journal-title":"Anal Chem"},{"key":"bib29","first-page":"2843","article-title":"Preclinical PET Study of Intravitreal Injections","volume":"58","author":"Fern\u00e1ndez-Ferreiro","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"5899","DOI":"10.1167\/iovs.10-6862","article-title":"PET\/CT imaging of I-124-radiolabeled bevacizumab and ranibizumab after intravitreal injection in a rabbit model","volume":"52","author":"Christoforidis","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1097\/00006982-199515050-00010","article-title":"Vancomycin levels after intravitreal injection. Effects of inflammation and surgery","volume":"15","author":"Aguilar","year":"1995","journal-title":"Retina"},{"issue":"3","key":"bib32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1167\/tvst.10.3.1","article-title":"Pharmacokinetics of intravitreal vancomycin and ceftazidime in silicone oil-filled macaque eyes","volume":"10","author":"Imamura","year":"2021","journal-title":"Transl Vis Sci Technol"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1167\/iovs.09-4140","article-title":"Pharmacokinetics of bevacizumab and its effect on vascular endothelial growth factor after intravitreal injection of bevacizumab in macaque eyes","volume":"51","author":"Miyake","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib34","doi-asserted-by":"publisher","first-page":"5877","DOI":"10.1167\/iovs.12-10164","article-title":"Effect of vitrectomy on aqueous VEGF concentration and pharmacokinetics of bevacizumab in macaque monkeys","volume":"53","author":"Kakinoki","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"6501","DOI":"10.1167\/iovs.15-17279","article-title":"Ranibizumab and aflibercept: intraocular pharmacokinetics and their effects on aqueous vegf level in vitrectomized and nonvitrectomized macaque eyes","volume":"56","author":"Niwa","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"148039","DOI":"10.1155\/2012\/148039","article-title":"Proteomic analyses of the vitreous humour","volume":"2012","author":"Angi","year":"2012","journal-title":"Mediators Inflamm"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s10237-012-0398-3","article-title":"Saccade movements effect on the intravitreal drug delivery in vitreous substitutes: a numerical study","volume":"12","author":"Modareszadeh","year":"2013","journal-title":"Biomech Model Mechanobiol"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0014-4835(91)90125-X","article-title":"The loss of fluorescein, fluorescein glucuronide and fluorescein isothiocyanate dextran from the vitreous by the anterior and retinal pathways","volume":"52","author":"Araie","year":"1991","journal-title":"Exp Eye Res"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/eye.1987.45","article-title":"Ageing of the vitreous","volume":"1","author":"Sebag","year":"1987","journal-title":"Eye"},{"key":"bib40","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/BF02160337","article-title":"Age-related changes in human vitreous structure","volume":"225","author":"Sebag","year":"1987","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"bib41","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1167\/tvst.8.3.56","article-title":"Age-related loss of human vitreal viscoelasticity","volume":"8","author":"Schulz","year":"2019","journal-title":"Transl Vis Sci Technol"},{"key":"bib42","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jconrel.2013.01.018","article-title":"Nanoparticle diffusion in, and microrheology of, the bovine vitreous ex vivo","volume":"167","author":"Xu","year":"2013","journal-title":"J Control Release"},{"key":"bib43","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.jpba.2010.12.027","article-title":"Effective electrophoretic mobilities and charges of anti-VEGF proteins determined by capillary zone electrophoresis","volume":"55","author":"Li","year":"2011","journal-title":"J Pharm Biomed Anal"},{"issue":"17","key":"bib44","doi-asserted-by":"publisher","first-page":"E992","DOI":"10.1097\/BRS.0000000000003028","article-title":"Transport of vancomycin and cefepime into human intervertebral discs: quantitative analyses","volume":"44","author":"Zhu","year":"2019","journal-title":"Spine"},{"key":"bib45","doi-asserted-by":"publisher","first-page":"5221","DOI":"10.1167\/iovs.12-9702","article-title":"Ocular pharmacokinetics of bevacizumab in vitrectomized eyes with silicone oil tamponade","volume":"53","author":"Xu","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Investigative Ophthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.67.8.36","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:32:18Z","timestamp":1791927138000},"score":1,"resource":{"primary":{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.67.8.36"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,7,1]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.67.8.36","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,14]]}}}